Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04315571 · ClinicalTrials.gov registry record · NA
Comparing Ascites Relief In Two Standard Treatments: Large Volume Paracentesis Vs. Early Tips Using Viatorr Controlled Expansion Stents
A NA study of Ascites and Hypertension, Portal, sponsored by University of California, Los Angeles.
- Active
- Registry status
- NA
- Development phase
- 68
- Enrollment target
- 1
- Study location
NCT04315571: Active NA study of Ascites and Hypertension, Portal, sponsored by University of California, Los Angeles.
NCT04315571 is a NA study of Ascites and Hypertension, Portal that is active but no longer recruiting, run by University of California, Los Angeles. The registered enrollment target is 68 participants, below the 130-participant average among 6 other Ascites trials with a reported enrollment target (48% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04315571, a NA study of Ascites and Hypertension, Portal, is active but no longer recruiting, sponsored by University of California, Los Angeles.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 68 participants
- Enrollment target
- 1
- Study location
Study Summary
For this study, the investigators will be collecting data based on patients' random selection to two different approved standard of care treatments for ascites: Subjects will get randomized into either Group A: Large Volume Paracentesis (LVP) with albumin infusion, or Group B: an early transjugular intrahepatic portosystemic shunt (TIPS) procedure.
Primary Outcome
The average number of paracentesis per week.
Conditions Studied
Interventions
- DEVICE Gore® Viatorr® Endoprosthesis with controlled expansion
- PROCEDURE Large Volume Paracentesis with albumin infusion
Study Locations (1)
California
- UCLA Medical Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2020-03-24 |
| Est. Completion | 2027-04-01 |
| Phase | NA |
What the registry record for NCT04315571 still lists
NCT04315571 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 68 participants, a relatively small participant target, below the 130-participant average among 6 other Ascites trials with a reported enrollment target (48% lower).
The record links to 2 conditions, with Ascites appearing as the primary indexed condition, and to 2 interventions - of which Gore® Viatorr® Endoprosthesis with controlled expansion is the first listed.
NCT04315571 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04315571 about?
NCT04315571 is a clinical study titled "Comparing Ascites Relief In Two Standard Treatments: Large Volume Paracentesis Vs. Early Tips Using Viatorr Controlled Expansion Stents". For this study, the investigators will be collecting data based on patients' random selection to two different approved standard of care treatments for ascites: Subjects will get randomized into either Group A: Large Volume Paracentesis (LVP) with albumin infusion, or Group B: an early transjugular ...
What is the current status of trial NCT04315571?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 68 participants. The study started on 2020-03-24. Estimated completion is 2027-04-01.
What conditions does trial NCT04315571 study?
This clinical trial studies the following conditions: Ascites, Hypertension, Portal.
What interventions are being tested in trial NCT04315571?
The interventions under investigation include: Gore® Viatorr® Endoprosthesis with controlled expansion (DEVICE), Large Volume Paracentesis with albumin infusion (PROCEDURE).
Who is sponsoring clinical trial NCT04315571?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04315571 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ascites
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A (M)Ulti-center, Prospective, (O)Pen Label, Uncontrolled Feasibility (S)Tudy to Assess the Safety and Effectiveness of an Automatic Low Flow (A)Scites (Alfa) Pump (I)n Patients With (C)Irrhosis and Refractory or Recurrent Ascites
COMPLETED · NA
-
High Dose Albumin in Refractory Ascites
RECRUITING · Phase 2
-
Vasoconstrictors as Alternatives to Albumin After Large-Volume Paracentesis (LVP) in Cirrhosis
COMPLETED · Phase 4
-
A Study of OCE-205 in Participants With Cirrhosis With Ascites Who Developed Hepatorenal Syndrome-Acute Kidney Injury
COMPLETED · Phase 2
-
Cirrhotic Ascites Treatment With Satavaptan in Patients With Ascites Due to Cirrhosis of the Liver (CATS)
COMPLETED · Phase 3
-
Satavaptan Dose-Ranging Study in Hyponatraemic Patients With Cirrhotic Ascites
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02044497 · 68 participants · Phase 4
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
- NCT03779854 · 68 participants · Phase 2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- NCT03821246 · 68 participants · Phase 2
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
- NCT04115514 · 68 participants · Phase 2
Treatment of ARDS With Instilled T3
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI